Eli Lilly Shares Hit All-Time High After FDA Approves Drug for Weight-Loss Treatment
- Investing News
admin
- 0
- 1 minute read
Eli Lilly shares hit an all-time high after receiving FDA approval for Zepbound, an injectable treatment to help people lose weight.
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-497277330-0ce0bc2661664a18ac4476b5be0eaa8d.jpg "On Which Financial Statements Do Companies Report Long-Term Debt?")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1055247044-c1c66750541b4532813e54d8bc5a1854.jpg "<div>Credit Rating vs. Equity Research: What's the Difference?</div>")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-518595670-91421a5730064d22b00fb052e694fdc8.jpg "<div>A Beginners' Guide to Managing Your Money</div>")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-2150743060-75c2828f7a4a4e13bf6af0d58576e290.jpg "How Starbucks Makes Money")
